Cortical Serotonin 5-HT _2A Receptor Binding and Social Communication in Adults With Asperger’s Syndrome: An in Vivo SPECT Study

We studied eight adult men with Asperger’s syndrome (full-scale IQ measured with the WAIS-III: >80, range=80–120; age: mean=26 years, SD=6) who were educated until they were at least 18 years and 10 healthy male comparison subjects who did not differ significantly in age or education. All volunteers were diagnosed with ICD-10 criteria and the Autistic Diagnostic Interview—Revised (7) . For people with Asperger’s syndrome, the mean scores on the Autistic Diagnostic Interview—Revised for domain A (qualitative abnormalities in reciprocal social interaction), domain B (qualitative abnormalities in communication), and domain C (repetitive behavior) were, respectively, mean=18 (SD=3), mean=13 (SD=6), and mean=6 (SD=3).

People were excluded if they had a history of physical or psychiatric disorder affecting brain function (e.g., epilepsy), a genetic disorder associated with autistic spectrum disorder (e.g., fragile X syndrome), or clinically abnormal magnetic resonance imaging. The study had ethical approval. No subject was taking any medication, and none reported past use of any psychotropic medication (e.g., selective serotonin reuptake inhibitors).

SPECT scans were performed at the Institute of Nuclear Medicine, Middlesex Hospital, University College London Medical School, with a three-headed PRISM 3000XP scanner (Phillips Medical Systems, Cleveland) with low-energy ultra-high-resolution fan-beam collimators. A bolus dose of 180 MBq of ¹²³ I-5-I-R91150 was administered intravenously. Sequential whole-brain images were acquired through a period of stable binding at pseudoequilibrium from 120 minutes to 280 minutes postinjection.

Whole-brain images were acquired with a resolution of 9–11 mm full width at half maximum. A transmission scan template, with a corresponding ¹²³ I-5-I-R91150 specific emission scan template, was generated. As previously described, data were analyzed with the researcher automatically blind to subject status (e.g., see reference 8). In brief, cerebellar and cortical regions of interest based on the Talairach atlas were drawn on the emission scan template brain, and subsequent automatic data analysis examined between-group differences independent of the operator. The individual reconstructed and realigned image volumes were coregistered to the template images by using a nine-parameter (three-translation, three-rotation, and three-scaling) transformation based on the transmission image. Thus, mean activity per voxel for each region of interest was generated automatically for each subject. Average cerebellar uptake was used as a reference region because it is virtually devoid of 5-HT _2A receptors. Thus, an estimated binding potential can be generated for each cortical region by calculating the cortical/cerebellar ratio for each cortical region during the period of pseudoequilibrium.

Data were first examined for normality of distribution to conform to the assumptions of the statistics employed. Between-group differences in mean 5-HT _2A estimated binding potential were examined by using a nonparametric test (Mann-Whitney U, two-tailed), and statistical significance was defined as p<0.05. Also, within those with Asperger’s syndrome, we carried out a preliminary analysis (with a nonparametric test: Kendall’s tau) of the relationship between estimated binding potential and clinical symptoms as measured by the score on each of the three domains of the Autistic Diagnostic Interview—Revised. To reduce the number of statistical comparisons, we correlated only the estimated binding potential of the brain regions that were significantly different from those of the comparison subjects.

The individuals with Asperger’s syndrome had a significantly lower mean 5-HT _2A estimated binding potential than the comparison subjects in the anterior and posterior cingulate cortex, in the frontal and superior temporal cortex bilaterally, and in the left parietal cortex ( Table 1 ). Also, estimated binding potential in the anterior and posterior cingulate and the right frontal cortex was significantly correlated with increased qualitative abnormalities in reciprocal social interaction (domain A of the Autistic Diagnostic Interview—Revised); in each of these three regions, r=–0.837 and p<0.02.

Our findings suggest that people with Asperger’s syndrome have a significant reduction in cortical 5-HT _2A receptors, supporting prior reports that people with autistic spectrum disorder have reduced serotonergic “responsivity” (4) and platelet 5-HT _2A receptor binding (4, 5) .

However, we studied adults and used parental reports of abnormal behavior and an analysis based on regions of interest. Hence, we do not know if our findings will generalize across the autistic spectrum (e.g., to children) or if abnormalities in 5-HT _2A estimated binding potential of specific subregions of the cortex relate to particular subtypes of social behavior (e.g., gaze avoidance or processing of facial emotion). Also, we carried out a number of statistical comparisons. Nevertheless, we compared group differences in mean estimated binding potential with two-tailed nonparametric statistical tests; seven of 15 regions were significantly different, and four more were nearly significant. Therefore, our findings are unlikely to be fully explained by type 1 error.

Reduced 5-HT _2A estimated binding potential of the cingulate, frontal, and temporal cortex was correlated with qualitative abnormalities in reciprocal social interaction. These regions are crucial to human social communication. Also, in the general population, cortical 5-HT _2A receptor density is related to personality traits for harm avoidance (3) . Furthermore, as noted above, the 5-HT _2A receptor gene is close to a region on chromosome 13q reported to be linked to autism (6) . Hence, differences in cortical 5-HT _2A receptor availability may partially explain some symptoms in people with Asperger’s syndrome. Furthermore, differences in the 5-HT system are of relevance to the treatment of autistic spectrum disorder (e.g., randomized trials of 5-HT reuptake inhibitors improve global severity ratings [9] ).

5-HT acts as a trophic or differentiation factor in the brain (10) . We found that people with Asperger’s syndrome had lower estimated binding potential in regions that are also anatomically abnormal in the disorder (11) . Furthermore, in people with Asperger’s syndrome, abnormal neuronal integrity of a frontal region, including the anterior cingulate, is also related to problems in social communication (12) . Thus, our findings may be confounded by differences in brain anatomy, and/or differences in the serotonergic system may affect brain development in autistic spectrum disorder.

Others have reported a link between repetitive behaviors and the serotonergic system. We found no relationship between these behaviors and cortical 5-HT _2A density in Asperger’s syndrome. This may reflect a lack of power or our inability to detect subtle regional differences in receptor density by using approaches based on regions of interest. Also, people with Asperger’s syndrome had significantly lower estimated binding potential in all of the brain regions we examined, but this only reached statistical significance in some regions. We do not suggest that people with Asperger’s syndrome have regionally specific differences in 5-HT _2A receptions. It is more likely that they have generalized abnormality, but it may affect some brain regions more than others.

Previous work in animals with ¹²³ I-5-I-R91150 has indicated a higher nonspecific binding in primates than in rats (13) . However ¹²³ I-5-I-R91150 has been validated for use in humans and has been used successfully in clinical populations (e.g., see reference 14 ).

In summary, adults with Asperger’s syndrome have abnormalities in cortical 5-HT _2A receptor density; this may be related to some clinical symptoms. Further work should directly relate differences in brain 5-HT receptors to behavior in larger groups.

Received Nov. 19, 2004; revisions received Feb. 8 and April 8, 2005; accepted April 26, 2005. From the Institute of Psychiatry, Department of Psychological Medicine, London; the Department of Psychiatry, College of Surgeons, Dublin; Middlesex Hospital, University College London, London; and Radionuclide Center, Vrije Universiteit, Amsterdam. Address correspondence and reprint requests to Dr. Murphy, P50, Institute of Psychiatry, DeCrespigny Park, London, SE58AF U.K.; [email protected] (e-mail).Supported by the South London and Maudsley National Health Service Trust, the Health Foundation, and the Medical Research Council United Kingdom AIMS Program.